Publications
- The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N-2-oxide2004 | Faculty of Science
- Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)2013 | Faculty of Science
- Preparation of a biologically active apo-cytochrome b5 via heterologous expression in Escherichia coli2009 | Faculty of Science
- Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method2009 | Faculty of Science
- Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A22008 | Faculty of Science
- Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice2008 | Faculty of Science
- DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells2007 | Faculty of Science, Second Faculty of Medicine
- Formation and persistence of DNA adducts of anticancer drug ellipticine in rats2007 | Faculty of Science
- Effect of benzo[a]pyrene treatment on hepatic cytochrrome P450 and NADPH: cytochrrome P450 reductase (POR) levels in mice with liver-specific deletion of the POR gene2007 | Faculty of Science
- The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism2007 | Faculty of Science
Loading network view...